XML 50 R37.htm IDEA: XBRL DOCUMENT
v3.26.1

Segments of Business (Tables) | 6 Months Ended
--- | ---
Jun. 28, 2026
Segment Reporting [Abstract] |
Schedule of Reportable Business Segments | The Company operates the business through the following three reportable business segments based on product categories:
Reportable Segments | Product Categories
Self Care | Cough, Cold, and Allergy
| Pain Care
| Other Self Care (Digestive Health, Smoking Cessation, Eye Care, and Other)
Skin Health and Beauty | Face and Body Care
| Hair, Sun, and Other
Essential Health | Oral Care
| Baby Care
| Other Essential Health (Women’s Health, Wound Care, and Other)
Schedule of Product Categories as a Percent of Net Sales | The Company’s product categories as a percentage of Net sales for the fiscal three and six months ended June 28, 2026 and June 29, 2025 were as follows:
|  | Fiscal Three Months Ended |  | Fiscal Six Months Ended
Product Categories |  | June 28, 2026 |  | June 29, 2025 |  | June 28, 2026 |  | June 29, 2025 |  |
Cough, Cold, and Allergy |  | 12 | % |  | 12 | % |  | 14 | % |  | 14 | % |  |
Pain Care |  | 11 |  |  | 12 |  |  | 12 |  |  | 12 |  |  |
Other Self Care |  | 17 |  |  | 17 |  |  | 16 |  |  | 16 |  |  |
Face and Body Care |  | 18 |  |  | 18 |  |  | 18 |  |  | 18 |  |  |
Hair, Sun, and Other |  | 10 |  |  | 9 |  |  | 10 |  |  | 9 |  |  |
Oral Care |  | 10 |  |  | 11 |  |  | 10 |  |  | 11 |  |  |
Baby Care |  | 10 |  |  | 9 |  |  | 9 |  |  | 9 |  |  |
Other Essential Health |  | 12 |  |  | 12 |  |  | 11 |  |  | 11 |  |  |
Total |  | 100 | % |  | 100 | % |  | 100 | % |  | 100 | % |  |
Schedule of Segment Net Sales and Adjusted Operating Income | Segment net sales and Segment adjusted operating income for the fiscal three and six months ended June 28, 2026 and June 29, 2025 were as follows:
|  | Fiscal Three Months Ended |  |
|  | June 28, 2026 |  | June 29, 2025 |  |
(Dollars in Millions) |  | Self Care |  | Skin Health and Beauty |  | Essential Health |  | Total |  | Self Care |  | Skin Health and Beauty |  | Essential Health |  | Total |  |  |  |
Net sales |  | $ | 1,589 |  |  | $ | 1,113 |  |  | $ | 1,253 |  |  | $ | 3,955 |  |  | $ | 1,555 |  |  | $ | 1,059 |  |  | $ | 1,225 |  |  | $ | 3,839 |  |  |  |  |
Segment adjusted Cost of sales(1) |  | 550 |  |  | 450 |  |  | 574 |  |  | 1,574 |  |  | 548 |  |  | 422 |  |  | 531 |  |  | 1,501 |  |  |  |  |
Other segment expense items(2) |  | 527 |  |  | 477 |  |  | 364 |  |  | 1,368 |  |  | 480 |  |  | 488 |  |  | 343 |  |  | 1,311 |  |  |  |  |
Segment adjusted operating income |  | $ | 512 |  |  | $ | 186 |  |  | $ | 315 |  |  | $ | 1,013 |  |  | $ | 527 |  |  | $ | 149 |  |  | $ | 351 |  |  | $ | 1,027 |  |  |  |  |
Reconciliation to Income before taxes |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Less: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Depreciation(3) |  |  |  |  |  |  |  | 79 |  |  |  |  |  |  |  |  | 78 |  |  |  |  |
Amortization of intangible assets(4) |  |  |  |  |  |  |  | 64 |  |  |  |  |  |  |  |  | 64 |  |  |  |  |
Separation-related costs(5) |  |  |  |  |  |  |  | 7 |  |  |  |  |  |  |  |  | 24 |  |  |  |  |
Restructuring expenses and operating model optimization initiatives(6) |  |  |  |  |  |  |  | 69 |  |  |  |  |  |  |  |  | 68 |  |  |  |  |
Conversion of stock-based awards(7) |  |  |  |  |  |  |  | — |  |  |  |  |  |  |  |  | 1 |  |  |  |  |
Founder Shares(8) |  |  |  |  |  |  |  | 1 |  |  |  |  |  |  |  |  | 5 |  |  |  |  |
Pending Transaction and other related costs(9) |  |  |  |  |  |  |  | 16 |  |  |  |  |  |  |  |  | — |  |  |  |  |
Skillman sale-leaseback |  |  |  |  |  |  |  | 2 |  |  |  |  |  |  |  |  | — |  |  |  |  |
Other operating expense, net |  |  |  |  |  |  |  | 6 |  |  |  |  |  |  |  |  | 5 |  |  |  |  |
General corporate/unallocated expenses |  |  |  |  |  |  |  | 70 |  |  |  |  |  |  |  |  | 90 |  |  |  |  |
Operating income |  |  |  |  |  |  |  | $ | 699 |  |  |  |  |  |  |  |  | $ | 692 |  |  |  |  |
Other expense, net |  |  |  |  |  |  |  | 11 |  |  |  |  |  |  |  |  | 10 |  |  |  |  |
Interest expense, net |  |  |  |  |  |  |  | 90 |  |  |  |  |  |  |  |  | 94 |  |  |  |  |
Income before taxes |  |  |  |  |  |  |  | $ | 598 |  |  |  |  |  |  |  |  | $ | 588 |  |  |  |  |
|  | Fiscal Six Months Ended |  |
|  | June 28, 2026 |  | June 29, 2025 |  |  |  |
(Dollars in Millions) |  | Self Care |  | Skin Health and Beauty |  | Essential Health |  | Total |  | Self Care |  | Skin Health and Beauty |  | Essential Health |  | Total |  |  |  |  |  |  |  |  |  |  |  |
Net sales |  | $ | 3,288 |  |  | $ | 2,172 |  |  | $ | 2,404 |  |  | $ | 7,864 |  |  | $ | 3,222 |  |  | $ | 2,036 |  |  | $ | 2,322 |  |  | $ | 7,580 |  |  |  |  |  |  |  |  |  |  |  |  |
Segment adjusted Cost of sales(1) |  | 1,128 |  |  | 887 |  |  | 1,092 |  |  | 3,107 |  |  | 1,135 |  |  | 835 |  |  | 1,027 |  |  | 2,997 |  |  |  |  |  |  |  |  |  |  |  |  |
Other segment expense items(2) |  | 1,023 |  |  | 931 |  |  | 698 |  |  | 2,652 |  |  | 994 |  |  | 960 |  |  | 705 |  |  | 2,659 |  |  |  |  |  |  |  |  |  |  |  |  |
Segment adjusted operating income |  | $ | 1,137 |  |  | $ | 354 |  |  | $ | 614 |  |  | $ | 2,105 |  |  | $ | 1,093 |  |  | $ | 241 |  |  | $ | 590 |  |  | $ | 1,924 |  |  |  |  |  |  |  |  |  |  |  |  |
Reconciliation to Income before taxes |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Less: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Depreciation(3) |  |  |  |  |  |  |  | 157 |  |  |  |  |  |  |  |  | 151 |  |  |  |  |  |  |  |  |  |  |  |  |
Amortization of intangible assets(4) |  |  |  |  |  |  |  | 129 |  |  |  |  |  |  |  |  | 127 |  |  |  |  |  |  |  |  |  |  |  |  |
Separation-related costs(5) |  |  |  |  |  |  |  | 10 |  |  |  |  |  |  |  |  | 62 |  |  |  |  |  |  |  |  |  |  |  |  |
Restructuring expenses and operating model optimization initiatives(6) |  |  |  |  |  |  |  | 147 |  |  |  |  |  |  |  |  | 135 |  |  |  |  |  |  |  |  |  |  |  |  |
Conversion of stock-based awards(7) |  |  |  |  |  |  |  | 1 |  |  |  |  |  |  |  |  | 4 |  |  |  |  |  |  |  |  |  |  |  |  |
Founder Shares(8) |  |  |  |  |  |  |  | 3 |  |  |  |  |  |  |  |  | 8 |  |  |  |  |  |  |  |  |  |  |  |  |
Pending Transaction and other related costs(9) |  |  |  |  |  |  |  | 32 |  |  |  |  |  |  |  |  | — |  |  |  |  |  |  |  |  |  |  |  |  |
Skillman sale-leaseback |  |  |  |  |  |  |  | 4 |  |  |  |  |  |  |  |  | — |  |  |  |  |  |  |  |  |  |  |  |  |
Other operating expense, net |  |  |  |  |  |  |  | 17 |  |  |  |  |  |  |  |  | 18 |  |  |  |  |  |  |  |  |  |  |  |  |
General corporate/unallocated expenses |  |  |  |  |  |  |  | 139 |  |  |  |  |  |  |  |  | 169 |  |  |  |  |  |  |  |  |  |  |  |  |
Operating income |  |  |  |  |  |  |  | $ | 1,466 |  |  |  |  |  |  |  |  | $ | 1,250 |  |  |  |  |  |  |  |  |  |  |  |  |
Other expense, net |  |  |  |  |  |  |  | 11 |  |  |  |  |  |  |  |  | 16 |  |  |  |  |  |  |  |  |  |  |  |  |
Interest expense, net |  |  |  |  |  |  |  | 185 |  |  |  |  |  |  |  |  | 188 |  |  |  |  |  |  |  |  |  |  |  |  |
Income before taxes |  |  |  |  |  |  |  | $ | 1,270 |  |  |  |  |  |  |  |  | $ | 1,046 |  |  |  |  |  |  |  |  |  |  |  |  |
(1) The Company defines Segment adjusted cost of sales as Cost of sales adjusted for amortization of intangible assets, operating model optimization initiatives, Separation-related costs, Pending Transaction and other related costs (as defined below), Founder Shares (as defined below), conversion of stock-based awards, and general corporate/unallocated expenses. (2) Other segment expense items for each reportable business segment include brand support, employee-related costs, shipping and handling costs, research and development costs, and certain other operating expenses (income). (3) Depreciation consists of depreciation of property, plant, and equipment and amortization of integration and development costs capitalized in connection with cloud computing arrangements. (4) Relates to the amortization of definite-lived intangible assets (primarily trademarks, trade names, and customer lists) over their estimated useful lives. (5) See Note 1, “Description of the Company and Summary of Significant Accounting Policies—Separation-Related Costs,” for additional information regarding Separation-related costs. (6) Restructuring expenses and operating model optimization initiatives relate to the 2026 Restructuring Initiative for the fiscal three and six months ended June 28, 2026 and the 2024 Multi-Year Restructuring Initiative for the fiscal three and six months ended June 29, 2025. See Note 15, “Restructuring Expenses and Operating Model Optimization Initiatives,” for additional information. Restructuring expenses and operating model optimization initiatives include accelerated depreciation expense on assets related to the 2026 Restructuring Initiative for the fiscal three and six months ended June 28, 2026. (7) Segment adjusted operating income excludes the impact of the conversion of stock-based awards that occurred on August 23, 2023. The adjustment represents the net impact of the gain on reversal of previously recognized stock-based compensation expense, offset by stock-based compensation expense recognized in the fiscal three and six months ended June 28, 2026 and June 29, 2025 relating to employee services provided prior to the Separation. (8) On August 25, 2023, the Company’s Compensation & Human Capital Committee approved equity grants to individuals employed by Kenvue as of October 2, 2023 (the “Founder Shares”). On October 2, 2023, the Founder Shares were granted to all Kenvue employees in the form of stock options and performance stock units to executive officers and either stock options and performance stock units or restricted stock units to non-executive individuals. (9) Pending Transaction and other related costs consist of expenses incurred in connection with the Pending Transaction, including advisory fees, legal costs, professional service costs, and other related costs (the “Pending Transaction and other related costs”). Depreciation and amortization by reportable business segment for the fiscal three and six months ended June 28, 2026 and June 29, 2025 were as follows:
|  | Fiscal Three Months Ended |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | Fiscal Six Months Ended
(Dollars in Millions) |  | June 28, 2026 |  | June 29, 2025 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | June 28, 2026 |  | June 29, 2025 |  |
Self Care |  | $ | 52 |  |  | $ | 53 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | $ | 105 |  |  | $ | 102 |  |  |
Skin Health and Beauty |  | 32 |  |  | 33 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 62 |  |  | 62 |  |  |
Essential Health |  | 59 |  |  | 56 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 119 |  |  | 114 |  |  |
Total depreciation and amortization(1) |  | $ | 143 |  |  | $ | 142 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | $ | 286 |  |  | $ | 278 |  |  |
(1) Depreciation consists of depreciation of property, plant, and equipment and amortization of integration and development costs capitalized in connection with cloud computing arrangements. Amortization relates to the amortization of definite-lived intangible assets over their estimated useful lives.

X
- Definition Schedule Of Reportable Segments + References No definition available. + Details
Name: | kvue_ScheduleOfReportableSegmentsTableTextBlock
Namespace Prefix: | kvue_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of revenue by product and service if it is not provided as part of reportable segment information. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 40 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-40 + Details
Name: | us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of segment reporting. Includes, but is not limited to, reconciliation of reportable segment amount to corresponding consolidated total. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 31 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-31 Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 34 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-34 Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 32 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32 Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 30 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30 Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 26C -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-26C Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 26B -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-26B Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 26A -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-26A Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 25 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-25 Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 22 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22 Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 15 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-15 + Details
Name: | us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_SegmentReportingAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration